VYLDA P TABLET is a combination of Pioglitazone and Vildagliptin which belongs to a group of medicines called Antidiabetic agents. It is used in the management of type 2 diabetes mellitus when it is not controlled by diet and exercise alone. Along management with VYLDA P TABLET follow regular exercise and diet plan as advised by the doctor to achieve better results.
Pioglitazone effectively controls blood sugar levels, and which is PPAR-gamma and PPAR-alpha agonist. It activates certain receptors (PPAR-gamma and PPAR-alpha) in the body which are involved in metabolizing glucose. This makes our body utilize insulin for digesting the circulating blood glucose which in turn decreases blood sugar levels. Additionally, it can also reduce the glucose produced by the liver. Vildagliptin controls blood glucose level by acting on the pancreas to produce more insulin and less glucagon which leads to low production of blood sugar levels resulting in controlled blood glucose levels.
VYLDA P TABLET is not recommended if you have diabetic ketoacidosis, abnormal growth cells in the bladder or blood in the urine. Before taking VYLDA P TABLET inform your doctor if you have pancreas disease, type 1 diabetes mellitus, retain water (fluid retention), macular oedema (swelling of the back of the eye) and polycystic ovary syndrome (women). This medicine is not recommended for use during pregnancy and breastfeeding. It is not suitable for use in children and adolescents under 18 years of age.
Do not drive or operate any machines if you experience abnormal vision or dizziness. The most common side effects of taking VYLDA P TABLET are headache, dizziness, joint pain, impotence, back pain, shortness of breath or flatulence. Contact your doctor if any of the above side effects worsen or persists for a longer duration.
No content available
